NCT00591292View on ClinicalTrials.gov

Phase I Study in Advanced Solid Tumors

PHASE1UnknownINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Solid Tumors
Interventions
DRUG

indibulin

Dose escalation of indibulin given twice daily for up to 6 months

Trial Locations (1)

Unknown

Santa Monica

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY